1. Home
  2. BIO vs AU Comparison

BIO vs AU Comparison

Compare BIO & AU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • AU
  • Stock Information
  • Founded
  • BIO 1952
  • AU 1944
  • Country
  • BIO United States
  • AU United States
  • Employees
  • BIO N/A
  • AU N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • AU Precious Metals
  • Sector
  • BIO Industrials
  • AU Basic Materials
  • Exchange
  • BIO Nasdaq
  • AU Nasdaq
  • Market Cap
  • BIO 8.7B
  • AU 9.6B
  • IPO Year
  • BIO N/A
  • AU 1972
  • Fundamental
  • Price
  • BIO $329.78
  • AU $28.53
  • Analyst Decision
  • BIO Buy
  • AU Hold
  • Analyst Count
  • BIO 4
  • AU 5
  • Target Price
  • BIO $369.00
  • AU $28.50
  • AVG Volume (30 Days)
  • BIO 204.1K
  • AU 1.6M
  • Earning Date
  • BIO 10-24-2024
  • AU 08-06-2024
  • Dividend Yield
  • BIO N/A
  • AU 0.77%
  • EPS Growth
  • BIO N/A
  • AU N/A
  • EPS
  • BIO N/A
  • AU 0.27
  • Revenue
  • BIO $2,562,604,000.00
  • AU $4,948,000,000.00
  • Revenue This Year
  • BIO N/A
  • AU $27.08
  • Revenue Next Year
  • BIO $4.49
  • AU $4.09
  • P/E Ratio
  • BIO N/A
  • AU $105.12
  • Revenue Growth
  • BIO N/A
  • AU 9.18
  • 52 Week Low
  • BIO $261.59
  • AU $14.91
  • 52 Week High
  • BIO $384.37
  • AU $32.57
  • Technical
  • Relative Strength Index (RSI)
  • BIO 55.50
  • AU 43.29
  • Support Level
  • BIO $326.40
  • AU $28.31
  • Resistance Level
  • BIO $338.79
  • AU $30.70
  • Average True Range (ATR)
  • BIO 7.90
  • AU 0.66
  • MACD
  • BIO 0.34
  • AU -0.43
  • Stochastic Oscillator
  • BIO 69.62
  • AU 5.16

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About AU AngloGold Ashanti PLC

Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.

Share on Social Networks: